NCT07072039Recruiting
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation (PEACE) Intervention
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
Chronic Obstructive Pulmonary Disease (COPD) is a serious lung condition that affects millions of people in the United States. Each year, it leads to about 150,000 deaths, nearly 900,000 emergency room visits, and 700,000 hospital stays. When COPD symptoms suddenly get worse-called an exacerbation-it can seriously harm a person's quality of life and often requires emergency care. Treating these flare-ups early can help prevent hospital visits, but right now, there aren't many good ways to make sure people get care quickly. Mobile Integrated Health (MIH) programs send specially trained paramedics, guided remotely by doctors, to care for patients in their homes. This approach could help people with COPD get faster, more effective care without needing to go to the hospital. In this project, the investigators are testing a new program called PEACE (Paramedic Evaluation for Acute COPD Exacerbation). The PEACE program sends community paramedics to patients' homes-when needed and in partnership with their regular doctors-to manage worsening COPD symptoms early. The study team will adapt the PEACE program to meet the needs of adults living at home with moderate to severe COPD, gather feedback from patients and healthcare providers, and run a small pilot study to see if the program is practical and helpful.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- First submitted
- 26 Jun 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Jul 2029
- Lead sponsor
- University of Massachusetts, Worcester
- Diseases
- COPD
- NCT number
- NCT07072039
What you commit to
- Study type: Interventional
- Planned participants: 75
- From 1 Oct 2025 to the primary completion date, 1 Jul 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- No prior diagnosis of COPD
Other
- Pregnancy
- Cannot provide informed consent
Who the study is looking for
- 1\) Diagnosis of COPD 4) Receives care in the UMass Memorial Medical Center System 5) 40 years of age or older 6) Speaks English 7) Resides in the geographical catchment area allowed by the UMass Memorial Medical Center MIH Program's license
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Massachusetts Chan Medical School Coordinator of this site? Confirm its status | Worcester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.